Roffman Miller Associates Inc. PA Raises Stock Position in AMETEK, Inc. (NYSE:AME)

Roffman Miller Associates Inc. PA increased its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 2.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 139,217 shares of the technology company's stock after acquiring an additional 3,970 shares during the quarter. AMETEK makes up about 1.5% of Roffman Miller Associates Inc. PA's portfolio, making the stock its 26th biggest holding. Roffman Miller Associates Inc. PA owned 0.06% of AMETEK worth $23,965,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AME. Vanguard Group Inc. grew its holdings in shares of AMETEK by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 26,147,772 shares of the technology company's stock worth $4,713,397,000 after buying an additional 282,208 shares in the last quarter. FMR LLC grew its holdings in shares of AMETEK by 1.1% during the fourth quarter. FMR LLC now owns 8,956,329 shares of the technology company's stock worth $1,614,468,000 after buying an additional 98,546 shares in the last quarter. Capital World Investors grew its holdings in shares of AMETEK by 70.0% during the fourth quarter. Capital World Investors now owns 5,760,017 shares of the technology company's stock worth $1,038,301,000 after buying an additional 2,371,062 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of AMETEK by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 5,526,369 shares of the technology company's stock worth $993,546,000 after buying an additional 124,713 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of AMETEK during the fourth quarter worth $697,080,000. Hedge funds and other institutional investors own 87.43% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Robert W. Baird dropped their target price on shares of AMETEK from $197.00 to $190.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Royal Bank Of Canada boosted their price target on shares of AMETEK from $194.00 to $201.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Morgan Stanley started coverage on shares of AMETEK in a research report on Monday, April 14th. They set an "equal weight" rating and a $170.00 price target on the stock. Truist Financial boosted their price target on shares of AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a research report on Monday, May 5th. Finally, Mizuho set a $212.00 price target on shares of AMETEK in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $197.89.

AMETEK Trading Up 1.2%

NYSE AME opened at $184.19 on Monday. The firm's 50-day moving average is $177.30 and its two-hundred day moving average is $177.02. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.41 and a quick ratio of 0.86. The stock has a market capitalization of $42.53 billion, a P/E ratio of 30.15, a PEG ratio of 2.76 and a beta of 1.09.

AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Thursday, May 1st. The technology company reported $1.75 EPS for the quarter, beating analysts' consensus estimates of $1.69 by $0.06. AMETEK had a net margin of 20.43% and a return on equity of 16.75%. The company had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the company posted $1.64 earnings per share. AMETEK's revenue for the quarter was down .2% compared to the same quarter last year. On average, sell-side analysts anticipate that AMETEK, Inc. will post 7.15 earnings per share for the current year.

AMETEK Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Friday, June 13th were given a dividend of $0.31 per share. The ex-dividend date was Friday, June 13th. This represents a $1.24 annualized dividend and a dividend yield of 0.67%. AMETEK's dividend payout ratio is presently 20.29%.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.